Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04MMJ
|
||||
| Former ID |
DPR000010
|
||||
| Drug Name |
ADX-2 series
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Schizophrenia [ICD9: 295; ICD10:F20] | Preclinical | [1] | ||
| Company |
Addex
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H27BrN2O
|
||||
| Canonical SMILES |
CCC1CC2CC3C1N(C2)CCC4=C3NC5=C4C=C(C=C5)OC.Br
|
||||
| InChI |
1S/C20H26N2O.BrH/c1-3-13-8-12-9-17-19-15(6-7-22(11-12)20(13)17)16-10-14(23-2)4-5-18(16)21-19;/h4-5,10,12-13,17,20-21H,3,6-9,11H2,1-2H3;1H
|
||||
| InChIKey |
NVBHPBGGYJRLTF-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | NMDA receptor | Target Info | Antagonist | [1] | |
| References | |||||
| REF 1 | The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.